Journal ArticleDOI
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Reads0
Chats0
TLDR
It is demonstrated here that the burden of PMS/PMDD as well as the disability adjusted life years lost due to this repeated-cyclic disorder is in the same magnitude as major recognized disorders.About:
This article is published in Psychoneuroendocrinology.The article was published on 2003-08-01. It has received 608 citations till now. The article focuses on the topics: Premenstrual dysphoric disorder & Premenstrual syndrome (PMS).read more
Citations
More filters
Journal ArticleDOI
Psychosis and autism as diametrical disorders of the social brain
TL;DR: Evidence regarding the genetic, physiological, neurological, and psychological underpinnings of psychotic-spectrum conditions supports the hypothesis that the etiologies of these conditions involve biases towards increased relative effects from imprinted genes with maternal expression, which engender a general pattern of undergrowth.
Journal ArticleDOI
Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems
TL;DR: Converging findings from recent experimental attempts suggest that prenatal infection can act as a "neurodevelopmental disease primer" that is likely relevant for a number of chronic mental illnesses.
Journal ArticleDOI
Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents
TL;DR: Clinicians and caregivers need to be aware of potential endocrine and metabolic adverse effects of psychiatric medications, and a careful selection of patients, choice of agents with potentially lesser risk for these adverse events, healthy lifestyle counseling, as well as close health monitoring are warranted.
Journal ArticleDOI
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Kimberly A. Yonkers,Candace Brown,Teri Pearlstein,Marie Foegh,Carole Sampson-Landers,Andrea J. Rapkin +5 more
TL;DR: A 24/4 regimen of drospirenone 3 mg and ethinyl estradiol 20 &mgr;g improves symptoms associated with premenstrual dysphoric disorder.
Journal ArticleDOI
The etiology, biology, and evolving pathology of premenstrual syndromes
TL;DR: Direct directions for clinically-relevant progress include identification of specific subgroups of menstrually-related syndromes, assessment of the genetic vulnerability and changes in vulnerability along the life cycle, the diversified mechanisms by which vulnerability is translated into pathophysiology and symptoms, the normalization process as well as syndrome-based and etiology-based clinical trials.
References
More filters
Journal ArticleDOI
A rating scale for depression
TL;DR: The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.
Journal ArticleDOI
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey
Ronald C. Kessler,Katherine A. McGonagle,Shanyang Zhao,Christopher B. Nelson,Michael R. Hughes,Suzann Eshleman,Hans-Ulrich Wittchen,Kenneth S. Kendler +7 more
TL;DR: The prevalence of psychiatric disorders is greater than previously thought to be the case, and morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders.
Book
The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.
TL;DR: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.
Journal ArticleDOI
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.
TL;DR: Evidence of strong covariation of depression and medical noncompliance suggests the importance of recognizing depression as a risk factor for poor outcomes among patients who might not be adhering to medical advice.